Search - tctmd.com

Displaying 61 - 80 of 149

Sort: Relevancy | Date

News Conference News TCT 2017

Compared With Provisional Stenting, Double-Kissing Crush Technique Reduces Left Main Disease Events at 1 Year

Yael L. Maxwell

October 30, 2017

News Industry News

STENTYS Completes Enrollment in the Study Assessing the Safety and Efficacy of Xposition S in Left Main Artery Lesions

July 28, 2017

News Industry News

STENTYS: Follow-Up of the APPOSITION IV and OPEN II Clinical Trials at Respectively 3 and 4 Years Confirms the Initial Positive Study Outcomes

May 25, 2017

Podcast

Episode 13: Left Main Revascularization, Bifurcation Stenting, and LAA Closure

May 17, 2017

News Opinion Fellow Talk

The Left Main Debate: What Does it Mean for the Future of Intervention?

Tiffany Patterson, MBBS

April 12, 2017

Presentation SIF 2017

Complex Bifurcation Case

Presenter: Jasvindar Singh

March 10, 2017

News Daily News

FDA Gives Thumbs Up to Side Branch Stent for Bifurcation Lesions

Todd Neale

March 06, 2017

News Daily News

Length Matters: More Adverse Events With Absorb BVS at 1 Year in Long Lesions

L.A. McKeown

March 02, 2017

Presentation JIM 2017

Simple and Complex Bifurcation Cases

Presenter: Robert-Jan van Geuns

February 23, 2017

News Daily News

Cobra Stent With Ultrathin Polymer Safe, Effective but Needs Testing in Tougher Patients

Michael O'Riordan

February 03, 2017

News Industry News

FDA Approves First Balloon Expandable Stent Graft for Use in the Iliac Artery

January 30, 2017

Presentation CHIP Florida 2017

Multivessel Disease and Low EF Case

Presenter: Raja Hatem

January 21, 2017

News Conference News TCT 2016

‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent

Michael O'Riordan

October 30, 2016

News Daily News

‘Reassuring’ 18-Month Results Seen With Absorb BVS, but Longer-Term Follow-up Still Needed

Michael O'Riordan

August 01, 2016

Presentation CCVVC 2016

Bifurcation Lesion Intervention: Preferred Two Stent Strategy

Presenter: Vinay K. Bahl

June 16, 2016

Presentation JIM 2016

BVS in BifurcationsBench tests and recommendations

Presenter: P.C. Smits

February 10, 2016

News Industry News

Medtronic Adds New Resolute Onyx(TM) Drug-Eluting Stent Sizes and Expands Indications

February 01, 2016

News Daily News

Residual Dissection After DCB Treatment for De Novo CAD Generally Resolves

Caitlin E. Cox

November 26, 2015

News Conference News TCT 2015

CENTURY II: Bioresorbable-Polymer DES Safe, Effective at 2 Years

October 13, 2015

News Daily News

DES Patients Who Bleed After Hospital Discharge Face Higher Mortality Risk

Todd Neale

August 31, 2015

Advertisement

Compared With Provisional Stenting, Double-Kissing Crush Technique Reduces Left Main Disease Events at 1 Year

STENTYS Completes Enrollment in the Study Assessing the Safety and Efficacy of Xposition S in Left Main Artery Lesions

STENTYS: Follow-Up of the APPOSITION IV and OPEN II Clinical Trials at Respectively 3 and 4 Years Confirms the Initial Positive Study Outcomes

Episode 13: Left Main Revascularization, Bifurcation Stenting, and LAA Closure

The Left Main Debate: What Does it Mean for the Future of Intervention?

Complex Bifurcation Case

FDA Gives Thumbs Up to Side Branch Stent for Bifurcation Lesions

Length Matters: More Adverse Events With Absorb BVS at 1 Year in Long Lesions

Simple and Complex Bifurcation Cases

Cobra Stent With Ultrathin Polymer Safe, Effective but Needs Testing in Tougher Patients

FDA Approves First Balloon Expandable Stent Graft for Use in the Iliac Artery

Multivessel Disease and Low EF Case

‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent

‘Reassuring’ 18-Month Results Seen With Absorb BVS, but Longer-Term Follow-up Still Needed

Bifurcation Lesion Intervention: Preferred Two Stent Strategy

BVS in BifurcationsBench tests and recommendations

Medtronic Adds New Resolute Onyx(TM) Drug-Eluting Stent Sizes and Expands Indications

Residual Dissection After DCB Treatment for De Novo CAD Generally Resolves

CENTURY II: Bioresorbable-Polymer DES Safe, Effective at 2 Years

DES Patients Who Bleed After Hospital Discharge Face Higher Mortality Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content